PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 31, 1981BMJ91 citationsOpen Access

Blood pressure reduction in elderly: a randomised controlled trial of methyldopa.

MSMargaret SpracklingJMJ.R.A. MitchellASA H Short

Structured PICO

Does methyldopa reduce cumulative mortality in elderly residents with diastolic blood pressure ≥100 mm Hg?

P
Population
n=123 elderly residents of local authority welfare homes in Nottinghamshire with standing or lying diastolic blood pressure of 100 mm Hg or more (screened from 549 residents).
I
Intervention
Methyldopa
C
Comparator
Simple observation
O
Outcome
Cumulative mortalityhard clinical

Treatment of moderate hypertension with methyldopa did not significantly alter cumulative mortality in this elderly population.

Abstract

A total of 123 out of 549 elderly residents of local authority welfare homes in Nottinghamshire were found at screening to have a standing or lying diastolic blood pressure of 100 mm Hg or more. These 123 subjects were randomly allocated to simple observation or to treatment with methyldopa. The cumulative mortality was similar in the observed and treated groups and in the normotensive group from which the subjects had been separated. Thus moderate hypertension, whether treated or not, was not a major risk predictor in the elderly population studied.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sprackling et al. (1981) studied this question.

synapsesocial.com/papers/6a0fa3f42badbc352afe784dhttps://doi.org/10.1136/bmj.283.6300.1151
Ask AI
Helpful
Bookmark
Share
View Full Paper